April 14, 2025
FDA Approves Bevacizumab Biosimilar
April 14, 2025
Ideal Apixaban Dose for Cancer-Associated VTE
April 14, 2025
Most Pediatric Cancer Deaths Occur in Regions of Conflict
April 11, 2025
Low-Dose vs Regular-Dose Apixaban for Prevention of VTE Recurrence in Patients With Cancer
Latest Headlines
View More
April 14, 2025
FDA Approves Bevacizumab Biosimilar
April 14, 2025
Ideal Apixaban Dose for Cancer-Associated VTE
April 14, 2025
Most Pediatric Cancer Deaths Occur in Regions of Conflict
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Conference Coverage
American Academy of Neurology Annual Meeting
April 14, 2025
Inebilizumab Effective for Myasthenia Gravis
April 10, 2025
Microplastics Linked to Brain Disability Spike
April 08, 2025
Distressing Dreams Tied to Early Death, Study
2025 ASCO GU
2024 ASH Annual Meeting
Clinical Guidelines
View More
Commentary & Perspectives
View More
FDA & Government News
View More
April 14, 2025
FDA Approves Bevacizumab Biosimilar
Business Management
View More
April 10, 2025
American Cancer Society Launches CEO Search
September 18, 2023
Cancer Moonshot Initiative Receives $240 Million Boost
September 11, 2023